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The TAG thoracic endograft is a commercially available device used for endovascular repair of thoracic aneurysms. It has
a single-action deployment mechanism, similar to its abdominal counterpart, consisting of an expanded polytetrafluo-
roethylene string, which is used to constrain the self-expanding stent graft within an integral external expanded
polytetrafluoroethylene corset. This report describes two cases of deployment failure of the TAG device and the bailout
techniques used to correct the problem and complete the procedure. In one case, this complication resulted in a
devastating intraoperative stroke that led to the death of the patient. Although this is an extremely rare occurrence, the
rapid recognition of the problem and ability to correct it by using catheter-based techniques are important during
endovascular treatment of thoracic aortic diseases using the TAG device. ( J Vasc Surg 2007;46:1032-5.)The TAG (W.L. Gore, Flagstaff, Ariz) device is a com-
mercially available endograft for treatment of descending
thoracic aortic aneurysms. The system was Food and Drug
Administration–approved in January 2005.1 Since then,
more than 1000 US physicians have been trained in its use,
and more than 10,000 implantations have been performed
worldwide. It has a one-step (Sim-Pull) deployment mech-
anism (Fig 1) similar to the abdominal Excluder (W.L.
Gore). This report describes two cases of failed deployment
of the TAG device and the salvage techniques used to
complete the procedure.
The TAG device is a nontapered, tubular stent graft
constructed of sinusoidal nitinol stent rings embedded in
layers of expanded polytetrafluoroethylene (ePTFE) and
fluorinated ethylene propylene graft material. It is delivered
through a separate 20F to 24F 35-cm introducer sheath
with a Keller-Timmerman pinch valve to prevent contact of
the bare device against the rough calcific surface of the
abdominal aorta and iliac arteries, which could risk prema-
ture deployment.
Similar to the abdominal Excluder, the TAG device is
deployed by using a single-step mechanism (Sim-Pull). A
single ePTFE string exits out of the distal end of the
delivery catheter through a modified Tuohy-Borst valve.
This string binds an ePTFE corset by using a proprietary
stitching pattern along a longitudinal seam that runs the
full length of the device and constrains the TAG device. By
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1032pulling on the string, the seam is opened, thus deploying
the self-expanding nitinol stent graft in situ. There are
additional ePTFE string loops at the ends that connect to
the delivery catheter to prevent excessive rotation of the
constrained device around the central hypotube. The pri-
mary string also releases these terminal control loops. The
delivery catheter has radiopaque “olives” that bookend and
longitudinally fix the constrained device on to the hypo-
tube. Unlike the abdominal Excluder, however, the TAG
device starts deploying in the middle and proceeds outward
in a bidirectional manner. The putative benefits of this
deployment include avoiding a windsock effect and effec-
tively halving the deployment time per given device length.
After control angiography, the delivery catheter is posi-
tioned and stabilized, and the Sim-Pull string is pulled with
a single, smooth motion under live fluoroscopy. The string
is removed intact and should be without evidence of frac-
ture or fraying; the delivery catheter is then carefully re-
Fig 1. The Sim-Pull string that is used to deploy the TAG device.
A single strand is used to stitch the seam and exits out of the distal
end of the delivery catheter.tracted back through the stent graft.
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Case 1. The patient was a 79-year-old woman who had a
7.5-cm distal arch thoracic aortic aneurysm. Preoperative evalua-
tion included a chest-abdomen-pelvis computed tomographic an-
giogram and a carotid duplex examination. There was no evidence
of any significant occlusive disease of the common carotid arteries
or the bifurcation. She underwent a right carotid-to-left subclavian
artery bypass with reimplantation of the left carotid artery to gain
an additional proximal landing zone, with a plan to perform a TAG
stent graft repair as a single stage under general anesthesia. A 22F
35-cm introducer sheath was advanced to the proximal abdominal
aorta, and a 31  100 mm device was inserted and positioned in
the transverse arch after control angiography. The deployment
string was pulled, but the proximal end of the device failed to
deploy. (Fig 2) The string came out intact without any evidence of
a break, and there was no resistance or other tactile cues that
indicated any irregularity. Initial attempts to gently tease the
leading olive tip through the undeployed proximal end resulted in
caudal movement of the device into the mid descending thoracic
aorta and partial intussusception of the proximal end into the
endograft. The entire delivery catheter was essentially trapped by
the nosecone, which could not be retracted through the unde-
ployed device, and the patient had a period of near-total thoracic
aortic occlusion.
The stent graft rode freely over the delivery catheter, and the
distal olive was used to push out the intussusception and “drag”
the stent graft back up to the proximal descending thoracic aorta.
Through the contralateral femoral access, an 0.018-inch guidewire
was introduced into the open distal end of the endograft and
passed through the space between the constrained end of the
device and the hypotube. A 4-mm balloon was used to initially
dilate the opening, which allowed exchange to an 0.035-inch
guidewire and serial dilation up to an 8-mm angioplasty balloon.
There was tight waisting of the balloon until at approximately 12
Fig 2. A, Initial aortogram showing the aneurysm and t
31  100 mm TAG device being delivered to the prox
undeployed.atm, when the constraining loop was broken and the end was fullyopened. The delivery catheter was removed, and two additional
TAG devices were required to complete the procedure. As the
device introducer sheath was being withdrawn, the iliac artery
became disrupted, thus necessitating temporary balloon control,
retroperitoneal exploration, and an iliofemoral bypass. The entire
procedure took approximately 5 hours, with a fluoroscopy time of
67 minutes, 160 mL of contrast, and blood loss of 2000 mL. After
surgery, the patient did not wake up from anesthesia, and a brain
magnetic resonance image revealed multiple bihemispheric infarcts
in the anterior and posterior circulations and watershed territories.
A computed tomographic angiogram showed that the stent grafts
were well positioned, the aneurysm was completely excluded with-
out an endoleak, and all the bypass grafts were patent. Despite
usual supportive measures, she did not to recover any meaningful
neurologic function and eventually died on postoperative day 68.
Although the exact etiology of the patient’s stroke could not be
ascertained, the likely causes include thromboemboli from the
extensive manipulation of the TAG device in the arch after it failed
to deploy and the transient intraoperative hypotension from the
iliac disruption.
Case 2. A 69-year-old man had a 6.1-cm type III thoracoab-
dominal aortic aneurysm and underwent a staged hybrid procedure
involving a retrograde ilioceliac and ilio–superior mesenteric artery
bypasses (stage 1) followed by a TAG stent graft (stage 2) repair 9
days later. The patient had end-stage renal failure that necessitated
chronic hemodialysis and therefore did not require revasculariza-
tion of the renal arteries. Under general anesthesia, a 24F 35-cm
sheath was introduced through the left femoral artery but was able
to be advanced only into the distal aorta as a result of the marginal
size and atherosclerotic disease of the iliac artery. A 37 200 mm
TAG device was inserted through this sheath to the proximal
descending thoracic aorta without significant difficulty. The de-
ployment cord was pulled, but the device failed to deploy at its
proximal end. Through a contralateral femoral access, an 0.014-
tra-anatomic revascularization of the arch vessels. B, The
arch. C, The proximal end of the TAG device remainshe ex
imalinch guidewire was used to initially traverse the constrained sec-
ak th
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8 atm were required to break the ePTFE loop (Fig 3). Remarkably,
a second 37 200 mm device, which was used to extend the repair
distally, again failed to deploy in a similar manner, and the same
salvage maneuvers had to be repeated (Fig 4). Comparison of the
stock numbers of the two devices did not indicate that they
came from the same batch. The procedure was completed
satisfactorily in 134 minutes, with 59 minutes of fluoroscopy,
270 mL of contrast, and 700 mL of blood loss. The patient had
an uneventful hospital course and was discharged on postoper-
ative day 3 without further complications. At 14 months, the
stent graft remained intact, and the aneurysm had decreased by
Fig 3. A, Undeployed TAG device in the proximal de
remains constrained. C, A 12-mm balloon is used to bre
Fig 4. The second device also failed to deploy completely within
the first device, which also did not deploy.4 mm with no endoleak.DISCUSSION
The two deployment failures reported in this article
represent a failure mode unique to this particular device. To
our knowledge, this complication has not been reported in
the literature. Failure modes of aortic endografts can be
broadly categorized into acute and late types. In the acute
category, almost all of the device-related failures are directly
or indirectly related to deployment and/or anatomic issues.
These can involve mechanical problems, as demonstrated in
these two cases, or technical issues due to operator error or
case selection.2-4 Although material or manufacturing is-
sues such as large needle holes, mispackaging, or mislabel-
ing may also occur, these have largely been avoided with
rigorous quality control. Late failures, conversely, are typ-
ically related to stent fractures and fabric erosions or pro-
gressive degenerative changes in the native artery.5,6
The TAG device has appealed to operators because of
its simplicity of deployment. However, this apparent sim-
plicity at the user end is gained at the expense of a complex
stitching pattern and series of interlocking loops that are
the Achilles heel of this deployment mechanism. Despite
the high tensile strength of the ePTFE material, each
centimeter of the seam and stitch can represent a failure
point from a break in the string. This is in contrast to the
conventional pin-pull-unsheathe mechanism of deploy-
ment used by most self-expanding stent platforms, which
also has its disadvantages, especially in the thoracic aorta.
Regardless of what method is used, it is important to have
some built-in fail-safe mechanism so that if the primary
mode fails, the delivery catheter can be deconstructed in
some manner to complete the process once the device is
partially deployed.
The causes of the device failures in these two cases
remain unsolved. As previously mentioned, the deploy-
ment strings in all three devices were carefully inspected,
and there was no evidence of any breaks. It is interesting
that the proximal end of the stent graft failed to deploy in
both cases. Clearly, the reverse situation in which the distal
ing thoracic aorta. B, The proximal end of the device
e loop and fully deploy the device.scendend remained constrained would have posed a greater
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created a true windsock, which could have pushed the
entire device distally until it wedged itself in a narrow
segment of the thoracoabdominal aorta, thus potentially
occluding vital branch vessels. Furthermore, the technique
described in this report of balloon fracture of the constrain-
ing loop would have been nearly impossible from a femoral
approach and would have required brachial access to gain
entry through the open proximal end of the stent graft. In
the worst-case scenario, in which both ends fail to deploy, it
would likely necessitate open conversion.
In conclusion, reliable deployment of an endograft is
critical to the safety of the patient and the success of the
procedure. Knowledge of bailout techniques, which are
unique to the failure modes of individual devices, is essen-
tial to the routine use of these devices. Nowhere is this truer
than for aortic endografts in the thoracic aorta. These
salvage maneuvers may require both endovascular and sur-
gical techniques, and this serves as a cogent argument for a
multidisciplinary approach to the treatment of these dis-
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